ADVANCED MALIGNANT SOLID NEOPLASM
Clinical trials for ADVANCED MALIGNANT SOLID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID NEOPLASM trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer clock: does morning or afternoon treatment work better?
Disease control Not yet recruitingThis study is testing whether the time of day a standard immunotherapy treatment is given affects how well it works for people with advanced solid tumors. Researchers want to see if a patient's internal body clock influences the treatment's effectiveness. About 160 participants w…
Matched conditions: ADVANCED MALIGNANT SOLID NEOPLASM
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Phone coaching aims to ease tough cancer care conversations
Symptom relief Not yet recruitingThis study is testing a phone-based coaching program called 'Talking About Cancer' to help patients with advanced cancer and their support person plan for future medical care. The goal is to see if these coaching sessions make it easier to have important conversations about treat…
Matched conditions: ADVANCED MALIGNANT SOLID NEOPLASM
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Could a simple recording help cancer patients remember Doctor's advice?
Knowledge-focused Not yet recruitingThis study aims to understand if recording a doctor's visit helps cancer patients remember important information and share it with family members who couldn't attend. Researchers will ask 200 patients with advanced cancer to record their clinic visit and then complete a survey ab…
Matched conditions: ADVANCED MALIGNANT SOLID NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:27 UTC